がん悪性腫瘍の精密管理のための統合戦略:デュアルモダリティ治療診断プローブ
Xilin Jing1,2,3, Yutao Li1,2,3, Yijing Zhang4
1Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
Abstract:
Cancer remains a formidable global public health challenge. Recent advancements in immunotherapy and targeted therapies have revolutionized diagnostic and therapeutic paradigms. Within this context, theranostics-an emerging field integrating molecular imaging with therapeutic interventions-has shown promise in achieving precision oncology. Central to theranostic platforms are dual-modality probes utilizing positron emission tomography, fluorescence, and magnetic resonance imaging technologies, which offer synergistic advantages such as complementary imaging modalities, intraoperative guidance, and real-time drug delivery monitoring. Despite growing research interest and early clinical trials, critical challenges persist in biosafety, metabolic stability, and imaging resolution. Structural optimization of probes and modality-specific selection based on cancer subtypes may address these limitations. This review systematically evaluates the design principles and clinical applications of dual-modality probes and proposes actionable strategies to enhance their translational potential.
関連する概念動画
Sensory Modalities
General senses refer to the broad category of sensory information detected by receptors in the body and can be further grouped into somatic and visceral senses. Somatic sensations include touch, pressure, temperature, and pain and are essential for navigating our environment and...
Uncertainty in Measurement: Accuracy and Precision
Accuracy and Precision
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Persuasion Strategies


